67 results
Page 3 of 4
S-1
hfrr0
12 Nov 21
IPO registration
5:03pm
8-K
EX-10.1
ay5elpkb
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
46qakt8z7x
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
vau28rc
14 May 21
Quarterly report
4:31pm
10-K
EX-10.1
6mjfm3k zq7m
31 Mar 21
Annual report
4:30pm
10-K
otnci63oy0ts lx8
31 Mar 21
Annual report
4:30pm
8-K
EX-10.2
jzdlrzwugg7qzcecx5
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
S-3
8zt2hg5cqk5xq88vg2
29 Jan 21
Shelf registration
4:48pm
S-8
EX-23.2
hf6v8329g o7my2mgni
22 Jan 21
Registration of securities for employees
4:15pm
S-8
5pnxhe1shu
22 Jan 21
Registration of securities for employees
4:15pm
S-8
EX-5.1
zkzjpeluh0cmenr
22 Jan 21
Registration of securities for employees
4:15pm
8-K/A
EX-99.1
r9mkc4vsmtfxy
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
xwywmi5ylnu0315
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-3.2
aj76hhyphl0eb
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-10.1
yxtizwrpy 8a7rj9s3si
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
6xvjez1dtg6mu5dtzg
2 Nov 20
Prospectus supplement
12:00am